Hyper‐CVAD in Adults With Acute Lymphoblastic Leukemia in Ecuador: A Multicenter Retrospective Study
Adult patients treated with the Hyper-CVAD protocol in Ecuador achieve rates of CR, MRD, and OS lower than those presented in international cohorts, as well as higher rates of treatment-related toxicity.
Authors
- Yaira Loor Morán (ORCID: https://orcid.org/0009-0009-8678-3790)
- Lorena Sánchez
- Andrés Orquera (ORCID: https://orcid.org/0000-0003-0143-2967)
- Brenner Sabando (ORCID: https://orcid.org/0000-0002-4462-5411)
- Jairo Quiñónez (ORCID: https://orcid.org/0000-0002-5572-7536)
- Teodoro Chisesi
- J C Armillas Oliveros (ORCID: https://orcid.org/0000-0002-9262-7171)
- Mónica Trujillo (ORCID: https://orcid.org/0000-0002-3667-1186)
- C Plaza (ORCID: https://orcid.org/0009-0008-1279-8749)
- Jhoanna Ramírez (ORCID: https://orcid.org/0009-0006-7949-0496)
- Maria Augusta Pacheco (ORCID: https://orcid.org/0000-0001-7628-8619)
- Danilo Navarrete (ORCID: https://orcid.org/0009-0009-2792-6456)
Institutions
- University of Guayaquil (EC)
- Institute for Transfusion Medicine (US)
- Universidad de las Artes (EC)
- Associazione Angela Serra per la Ricerca sul Cancro (IT)
- Hospital Luis Vernaza (EC)
- Universidad Técnica de Manabí (EC)
- Hospital Vozandes (EC)
- Instituto Ecuatoriano de Enfermedades Digestivas (EC)
Publication Details
- Journal
- Advances in Hematology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1155/ah/9995923
- Primary Topic
- Acute Lymphoblastic Leukemia research
- Type
- article
- Field-Weighted Citation Impact
- 0.00